How Tumor Cells Acquire Resistance to Kinase Inhibitors.

Discusses how tumor cells acquire resistance to kinase inhibitors. Importance of understanding the mechanisms in which tumors become resistant to a particular agent; Information on kinases and epidermal growth factor receptor; Results of a study by William Pao and colleagues on patients with non-small cell lung cancer who initially responded to getifinib and erlotinib treatment.